PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.02%
Positive revenue growth while MZX.DE is negative. John Neff might see a notable competitive edge here.
15.57%
Positive gross profit growth while MZX.DE is negative. John Neff would see a clear operational edge over the competitor.
251.12%
Positive EBIT growth while MZX.DE is negative. John Neff might see a substantial edge in operational management.
251.12%
Positive operating income growth while MZX.DE is negative. John Neff might view this as a competitive edge in operations.
24.37%
Positive net income growth while MZX.DE is negative. John Neff might see a big relative performance advantage.
20.00%
Positive EPS growth while MZX.DE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while MZX.DE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
7.82%
Share reduction more than 1.5x MZX.DE's 18.53%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
7.82%
Diluted share reduction more than 1.5x MZX.DE's 18.53%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Dividend reduction while MZX.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-52.88%
Negative OCF growth while MZX.DE is at 140.08%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-74.16%
Negative FCF growth while MZX.DE is at 19.48%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
64.62%
Positive 10Y revenue/share CAGR while MZX.DE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
64.62%
5Y revenue/share CAGR above 1.5x MZX.DE's 8.38%. David Dodd would look for consistent product or market expansions fueling outperformance.
29.67%
Positive 3Y CAGR while MZX.DE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
226.96%
Net income/share CAGR above 1.5x MZX.DE's 120.09% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
226.96%
5Y net income/share CAGR above 1.5x MZX.DE's 33.33%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
100.21%
3Y net income/share CAGR of 100.21% while MZX.DE is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
109.56%
Equity/share CAGR of 109.56% while MZX.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
109.56%
5Y equity/share CAGR above 1.5x MZX.DE's 49.03%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
77.45%
3Y equity/share CAGR above 1.5x MZX.DE's 18.15%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.31%
Our AR growth while MZX.DE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
9.16%
Inventory growth well above MZX.DE's 4.65%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.04%
Asset growth above 1.5x MZX.DE's 1.15%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.22%
Positive BV/share change while MZX.DE is negative. John Neff sees a clear edge over a competitor losing equity.
-12.02%
We’re deleveraging while MZX.DE stands at 5.37%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
10.69%
SG&A growth well above MZX.DE's 2.76%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.